Looks like an attempted "do over". Having botched the previous announcement of the results they are taking a mulligan. TH is saying to the market "look at me, look at me" before rehashing already released results in a more palatable form ie without a CR attached. For the sake of existing SHs I hope it works.
Ann: Phase II/III ASD Trial Successfully Meets Primary Endpoint, page-11
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
